News

Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new cardiovascular development partnership. Cardurion, a recently launched Boston-area…
Read More...

Flex Pharma has initiated a Phase 2 randomized, controlled, double-blinded, parallel design trial in the US. The COMMEND trial will evaluate FLX-787, the Company’s co-activator of…
Read More...

SiO2 Medical Products, Inc., a U.S.-based designer, developer, manufacturer, and supplier of pharmaceutical packaging, labware, and consumables products, and Sanaria Inc., a U.S.-based…
Read More...

Generex Biotechnology Corporation announced that its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com) has entered into a clinical trial collaboration agreement…
Read More...

Zoetis Inc. and Nexvet Biopharma plc announced that Zoetis has completed the acquisition of Nexvet, a biologic therapeutics company developing a pipeline of monoclonal antibody (mAb)…
Read More...

AbbVie Inc said on Friday it had received European approval to market its drug for treatment of all six major forms of hepatitis C. The company said the approval of Maviret was…
Read More...

Otsuka Pharmaceutical Co., Ltd., a wholly owned subsidiary of Otsuka Holdings Co., Ltd. and a global holistic healthcare company dedicated to bettering the health of people worldwide,…
Read More...

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that it has entered into a global strategic license with NantCell,…
Read More...

Baxter International Inc., a global medical products company, today announced the completion of the acquisition of Claris Injectables Limited, a global generic injectables…
Read More...

QS Pharma, the Contract Development and Manufacturing Organisation (CDMO), which was acquired by Quotient Clinical in February 2017, today announced it has received approval from the…
Read More...

Jazz Pharmaceuticals plc announced that it has entered into a license agreement with XL-protein GmbH ("XLp") for the rights to develop, manufacture and commercialize products using…
Read More...

AstraZeneca and Merck & Co., Inc., known as MSD outside of the United States and Canada, announced that they have entered a global strategic oncology collaboration to co-develop and…
Read More...

Takeda Pharmaceutical Company Limited and BioSurfaces, Inc. announced today that they have entered into an agreement to initiate a research program designed to develop innovative…
Read More...

Brainstorm Cell Therapeutics announced that the California Institute for Regenerative Medicine (CIRM) has awarded Brainstorm a grant of $16 million to support the pivotal Phase 3 study…
Read More...

Takeda Pharmaceutical Company Limited and Schrödinger announced the formation of a multi-target research collaboration directed to diseases that align with Takeda’s core therapeutic…
Read More...

Boehringer Ingelheim announced a $217 million investment to upgrade and expand their Fremont manufacturing facility. This investment will bring nearly 300 new high-wage and…
Read More...

STA Pharmaceutical Co., Ltd. – a WuXi AppTec subsidiary and the leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing –…
Read More...

BioLight Life Sciences announced successful results from its glaucoma insert VS101 ("Eye-D latanoprost insert") Phase 1/2a clinical trial, which demonstrated its ability to lower…
Read More...

Medidata announced that BeiGene, a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, will expand…
Read More...

Pfizer Inc. and Basilea Pharmaceutica announced that they have completed the licensing agreement whereby Pfizer has obtained the exclusive commercialization rights in Europe to CRESEMBA…
Read More...